Biocon Limited stock forecast
Want to see IN:BIOCON full AI Analyst Report?
Biocon Limited (BIOCON) Stock Forecast & Price Target
BIOCON Analyst Ratings
BIOCON Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Axis Direct | ₹435 | buy | 18.24%Upside | Reiterated | 02/16/26 | |||
| Antu Eapan Thomas | Geojit Research | ₹312→₹439 | buy | 19.33%Upside | Upgraded | 01/02/26 | ||
| ICICI Securities | ₹380→₹350 | sell | -4.87%Downside | Downgraded | 12/10/25 | |||
| Motilal Oswal | ₹460 | buy | 25.03%Upside | Reiterated | 12/08/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyReiterated₹435 | 02/16/26 | 18.24%Upside | |||
| Antu Eapan ThomasGeojit Research | BuyUpgraded₹312→₹439 | 01/02/26 | 19.33%Upside | ||
| SellDowngraded₹380→₹350 | 12/10/25 | -4.87%Downside | |||
| BuyReiterated₹460 | 12/08/25 | 25.03%Upside |
Best Analysts Covering Biocon Limited
Copying Antu Eapan Thomas's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -10.95% per trade.
Copying Antu Eapan Thomas's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.30% per trade.
Copying Antu Eapan Thomas's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.30% per trade.
BIOCON Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, BIOCON has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIOCON average Analyst price target in the past 3 months is ―.
BIOCON Financial Forecast
BIOCON Earnings Forecast
Next quarter’s earnings estimate for BIOCON is INR 1.30 with a range of INR 1.30 to INR 1.30. The previous quarter’s EPS was INR 0.30. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
BIOCON Sales Forecast
Next quarter’s sales forecast for BIOCON is INR 47.71B with a range of INR 47.29B to INR 48.14B. The previous quarter’s sales results were INR 43.89B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

